Immunotherapy of renal cell carcinoma
✍ Scribed by Cécile Gouttefangeas; Arnulf Stenzl; Stefan Stevanović; Hans-Georg Rammensee
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 439 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Therapy for disseminated renal cell carcinoma (RCC) is a major problem, as RCC is almost completely resistant to standard therapeutic approaches such as chemotherapy or radiotherapy. The search for innovative strategies has led to new concepts based on the assumption that the cellular or soluble med
Much remains to be learned about the immune response in human neoplasia both in a phenomenological sense and in its therapeutic possibilities. Recruitment of immune response mechanisms in the defense against cancer development and in the cure of advanced disease, though theoretically sound, remains
## Abstract ## BACKGROUND The current study was performed to determine the impact of the presence of retroperitoneal lymphadenopathy on the survival and response to immunotherapy of patients with metastatic renal cell carcinoma (RCC). ## METHODS A retrospective cohort study was performed with ou